Clinical trial
Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at…
NCT00317707 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00317707 |
|---|---|
| Title | Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk |
| Official title | Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | N-3 Polyunsaturated Fatty Acids, Placebo: Olive oil |
| Enrollment | 12,513 |
| Start date | Feb 1, 2004 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Apr 25, 2006 |
| Last update posted | Jan 18, 2012 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: